Mapping Cancer’s Life Story
Nov 19, 2026 · 33m
More Science podcasts
Summary
World-leading cancer researcher Mariam Tuma discusses the complexities of lung cancer, including the biology of cachexia and the use of precision medicine. She highlights the PEACE autopsy study and TracerX, which reveal how cancers evolve and evade the immune system. Tuma also explains the LungVax trial, a first-in-human vaccine designed to prevent recurrence, and shares her optimistic view that collaborative, multidisciplinary efforts can eventually conquer cancer.
Topics discussed
Opening message: Hope and ambition in cancer research
Episode intro and recap of previous Cancer Research UK stories
The mystery of cachexia: a wasting syndrome in advanced cancer
Introduction of Professor Mariam Jamalhanjani and her background
From physics to medicine: Mariam's career pivot
Lung cancer advancements: precision medicine and non-smokers
The big questions driving cancer research today
Understanding cachexia biology: why eating more doesn't help
The complexity of cachexia: multiple systems and targets
Team CanCan progress: tools, GDF15, and clinical trials
The PEACE study: using autopsies to understand cancer spread
Lessons from autopsies and the TracerX blood study
LungVax: the first lung cancer prevention vaccine trial
Extra-chromosomal DNA (ecDNA) and new treatment targets
Optimism and the breakthrough of immunotherapy
Personal stories: cervical cancer and the impact of prevention
Closing message: Hope, community, and legacy
Outro: Golden age of research and supporting Cancer Research UK
More from The Rest Is Science
Listen ad-free on Castria